Meta Health (SGX:5DX) addressed queries from the Singapore Exchange regarding its acquisition of a 55% stake in Jas Medical Screening Centre, according to a Thursday filing on the Singapore Exchange.
The company clarified that earn-out shares, valued at SG$77,770 per tranche, were calculated based on performance targets of SG$175,000 in annual net profit.
Adjustments to the earn-out shares will be independently reviewed, replacing the need for auditor opinions, Meta Health said.
Regarding its option agreement, the company said it allows flexibility for corporate transactions and divestments. The purchase price of option shares will be determined by mutual agreement or an expert valuer.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.